Page 1,348«..1020..1,3471,3481,3491,350..1,3601,370..»

Healthcare Nanotechnology (Nanomedicine) Market to Witness Growth Acceleration During 2015 2021 – Trading Herald

Posted: September 22, 2019 at 5:44 pm

Nanotechnology is one of the most promising technologies in 21st century. Nanotechnology is a term used when technological developments occur at 0.1 to 100 nm scale. Nano medicine is a branch of nanotechnology which involves medicine development at molecular scale for diagnosis, prevention, treatment of diseases and even regeneration of tissues and organs. Thus it helps to preserve and improve human health. Nanomedicine offers an impressive solution for various life threatening diseases such as cancer, Parkinson, Alzheimer, diabetes, orthopedic problems, diseases related to blood, lungs, neurological, and cardiovascular system.

Get Sample Copy of this report at https://www.persistencemarketresearch.com/samples/6370?source=atm

Development of a new nenomedicine takes several years which are based on various technologies such as dendrimers, micelles, nanocrystals, fullerenes, virosome nanoparticles, nanopores, liposomes, nanorods, nanoemulsions, quantum dots, and nanorobots.

In the field of diagnosis, nanotechnology based methods are more precise, reliable and require minimum amount of biological sample which avoid considerable reduction in consumption of reagents and disposables. Apart from diagnosis, nanotechnology is more widely used in drug delivery purpose due to nanoscale particles with larger surface to volume ratio than micro and macro size particle responsible for higher drug loading. Nano size products allow to enter into body cavities for diagnosis or treatment with minimum invasiveness and increased bioavailability. This will not only improve the efficacy of treatment and diagnosis, but also reduces the side effects of drugs in case of targeted therapy.

Request Report Methodology at https://www.persistencemarketresearch.com/methodology/6370?source=atm

Global nanomedicine market is majorly segmented on the basis of applications in medicines, targeted disease and geography. Applications segment includes drug delivery (carrier), drugs, biomaterials, active implant, in-vitro diagnostic, and in-vivo imaging. Global nanomedicine divided on the basis of targeted diseases or disorders in following segment: neurology, cardiovascular, oncology, anti-inflammatory, anti-infective and others. Geographically, nanomedicine market is classified into North America, Europe, Asia Pacific, Latin America, and MEA. Considering nanomedicine market by application, drug delivery contribute higher followed by in-vitro diagnostics. Global nanomedicine market was dominated by oncology segment in 2012 due to ability of nanomedicine to cross body barriers and targeted to tumors specifically however cardiovascular nanomedicine market is fastest growing segment. Geographically, North America dominated the market in 2013 and is expected to maintain its position in the near future. Asia Pacific market is anticipated to grow at faster rate due to rapid increase in geriatric population and rising awareness regarding health care. Europe is expected to grow at faster rate than North America due to extensive product pipeline portfolio and constantly improving regulatory framework.

Major drivers for nanomedicine market include improved regulatory framework, increasing technological know-how and research funding, rising government support and continuous increase in the prevalence of chronic diseases such as obesity, diabetes, cancer, kidney disorder, and orthopedic diseases. Some other driving factors include rising number of geriatric population, awareness of nanomedicine application and presence of high unmet medical needs. Growing demand of nanomedicines from the end users is expected to drive the market in the forecast period. However, market entry of new companies is expected to bridge the gap between supply and demand of nanomedicines. Above mentioned drivers currently outweigh the risk associated with nanomedicines such as toxicity and high cost. At present, cancer is one of the major targeted areas in which nanomedicines have made contribution. Doxil, Depocyt, Abraxane, Oncospar, and Neulasta are some of the examples of pharmaceuticals formulated using nanotechnology.

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are: North America U.S Canada Europe France, Germany, Italy, Spain, and the UK Eastern Europe CIS APAC China India Japan Australia Others Latin America Argentina Brazil Others

Key features of this report Drivers, restraints, and challenges shaping the Healthcare Nanotechnology (Nanomedicine) market dynamics Latest innovations and key events in the industry Analysis of business strategies of the top players Healthcare Nanotechnology (Nanomedicine) market estimates and forecasts(2015 -2021)

Request to view TOC at https://www.persistencemarketresearch.com/toc/6370?source=atm

Read the original here:
Healthcare Nanotechnology (Nanomedicine) Market to Witness Growth Acceleration During 2015 2021 - Trading Herald

Posted in Nano medicine | Comments Off on Healthcare Nanotechnology (Nanomedicine) Market to Witness Growth Acceleration During 2015 2021 – Trading Herald

Functional Polymer Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2027 – The Market Plan

Posted: September 22, 2019 at 5:44 pm

Global Functional Polymer Market: An Overview

The global functional polymers market is expected to expand at a healthy growth rate during 2018-2026. The market is witnessing a rising demand for functional polymers, due to their diverse application as catalysts, reagents, protecting groups, and many others. Their additional mechanical stability and functioning reactions are key to end-user industries. Additionally, these polymers can also be molded in physical shapes and for enhancing chemical reactions, thanks to their flexible industrial nature.

Their wide ranging applications include washing agents in agriculture and medicine. Growing demand for dyes is also driving growth for the functional polymer market. Functional polymers offer a wide variety of benefits for coloring hair through properties such as thermal stability, biocompatibility, chemical stability, solvent resistance, and great color fastness. The functional polymer market is also witnessing growth due to functional and surface coatings. Polymer coating provide an added advantage of superior protection and adherence from corrosion. Furthermore, polymers use as a catalyst for a wide variety of chemical reactions in industries are likely to generate considerable growth for the functional polymer market in the near future.

Global Functional Polymer Market: Notable Developments According to a new study, polymer-based Nano medicine can revolutionize the treatment of cancer in the near future. As per the study published in the Journal of American Chemical Society (JACS), polymer and Nano medicine combination results in negligible immunotoxicity and high level of therapeutic performance for cancers. Researchers in the study developed a theranostic supramolecular polymer using -cyclodextrin as the host. This advanced potion delivered superior ant metastasis capability, and antitumor performance. This development can propel the functional polymer market significantly, thanks to a growing number of cancers worldwide. Polymer based techniques are widely being experimented in the medical sector. A recent study has paved way for artificial limbs, guided by light. A new polymer based material mechanism enables shrinking of materials and changes in shape as needed. The study presented at American Chemical Societys national meeting, the researcher said, they can apply the new polymer in any 3D network and turn it into a stimuli-responsive material. Growing research and development activities such as these driven by growing interest in polymers are expected to create significant opportunities for many players in the functional polymer market.

Global Functional Polymer Market: Key Trends

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/functional-polymer-market.html

The global functional polymer market is expected to expand significantly in the near future, thanks to a rising demand for lightweight material. The materials are rising in demand due in automotive and aerospace industries as well. Additionally, increased in medical applications and depleting petrochemical resources are also expected to drive growth for the functional polymer market.

Growth of bio-based functional polymers is also a positive sign for the functional polymer market. These polymers, derived from agricultural feedstock such as potatoes and corn is lowering dependency on petrochemicals through products such as polybutylene succinate (PBS), polyethylene terephthalate (PET), polyethylene (PE), and polypropylene (PP).

Global Functional Polymer Market: Regional Outlook

The global functional polymer market report will be divided into several main regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The functional polymer market is expected to grow significantly in North America due to growing investment in medical breakthroughs, and growing demand in 3D applications. Additionally, rising automotive and defense related applications are also expected to drive growth in Asia Pacific region in the functional polymer market.

Global Functional Polymer Market: Competitive Dynamics

The global functional polymer market is a competitive and fragmented landscape. Increased innovation and low cost initial investments are driving growth for the functional polymer market in many regions. Some key players in the functional polymer market are Schneider Electric, Honeywell, Federal Signal Corporation, WERMA Signaltechnik, Larson Electronics, and Eaton.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=66401&source=atm

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=66401&source=atm

View original post here:
Functional Polymer Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2027 - The Market Plan

Posted in Nano medicine | Comments Off on Functional Polymer Market Insights, Trends, Analysis, Types, Applications, key players, Market shares and Forecast 2019 to 2027 – The Market Plan

Nanotechnology in Medical Applications Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 – Market Forecast

Posted: September 22, 2019 at 5:44 pm

Global Nanotechnology in Medical Applications Market: Overview

In the 20th century, developments in the field of nanotechnology and the applications of the technology in pharmaceuticals and medicines have increased significantly. Nanotechnology uses individual molecules, compounds, or atoms in various structures to produce devices and materials with unique characteristics. It works on matter with dimensions that could range from 1 nanometer to 100 nanometer. Nanotechnology has applications in the formation of various types of nano devices and nano materials. Nanomedicine is a signficant application of nanotechnology. Nanotechnology drugs are used in the field of medicine and health. Nanomedicine makes use of nano electronic biosensors and nano materials. It enables improved diagnosis, early detection and prevention, and proper treatment and examination of diseases. Nanomedicine involves interactions between nano devices and bio molecules in extracellular medium as well as inside human cells. Performance and functioning of drugs at a nano scale is varied from the one seen in a micro scale. The use of nanotechnology can improve the detection of the root cause of diseases and treat the damage that has occurred in the human body. The effect of nanomedicine drugs is faster than that of traditional drugs. Nanomedicine drugs can be used to target specific diseases.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/nanotechnology-in-medical-applications-market.html

The invention of nanotechnology has benefitted human health to a large extent. Advancements in nanotechnology can help repair and reproduce damaged tissue of the body. Nanotechnology enables the production of artificially stimulated cells that are used in tissue engineering. This helps in the development of artificial implants or transplantation of organs. Nanorobots can be modified to repair particular diseased cells. They function in the same way as antibodies that aid in the natural healing processes within the body. Nanotechnology has signficant contributions in the field ofstem cell research. Gold nanoparticles are used in the detection of targeted nucleic acids, with their sequence to recognize the treatment. Gold nanoparticles are being tested for use in the treatment of cancer and other serious harmful diseases. Nanotechnology is being used for developing instruments that purity the human blood. Magnetic microparticles aid in the separation of proteins and cells from complex media, thus helps in the examination of infections in diseases such as sepsis.

Global Nanotechnology in Medical Applications Market: Key Trends

The global nanotechnology in medical applications market is expected to expand at a rapid pace in the coming years. Research and development in nanomedicine is expected to drive the market. Moreover, government funding programs specifically for nanotechnology in key regions are expected to augment the market. However, long drawn out product approval processes and high costs of nanotechnology-based medical devices and products are expected to inhibit the growth of the nanotechnology in medical application market from 2018 to 2026.

Request Brochure of this report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62175&source=atm

Global Nanotechnology in Medical Applications Market: Segmentation

The global nanotechnology in medical applications market can be segmented based on product, application, and region. Based on product, the global nanotechnology in medical applications market can be classified into nanoparticles, biochips, medical textiles, implantable materials, active implantable devices, wound dressings, and others. The implantable materials segment can be further divided into dental filling materials and bone restorative materials. The active implantable devices segment can be further divided into cardiac rhythm management devices, hearing aid devices, and retinal implants. The active implantable devices segment is expected to constitute a prominent share of the global nanotechnology in medicine application market. In terms of application, the market can be categorized into drug delivery & therapeutics, diagnostics techniques, and others.

Global Nanotechnology in Medical Applications Market: Regional Analysis

Based on region, the global nanotechnology in medical applications market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is expected to expand at a robust pace, due to an increase in research efforts, rise in geriatric population, and increase in R&D expenditure on nanotechnology in the region.

Global Nanotechnology in Medical Applications Market: Competitive Landscape

Prominent players operating in the global nanotechnology in medical applications market are AstraZeneca, Ablynx, Abraxis BioScience Inc (Celgene Corporation), BioForce Nanosciences, Calando Pharmaceuticals, Inc., Elan (Alkermes), Kereos, Inc, Kleindiek Nanotechnik GmbH, MagForce AG, BlueWillow Biologics, Nanobiotix, Nanocopoeia, LLC., and Transgenex Nanobiotech, Inc.. among others. The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa) The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period. Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=62175&source=atm

Go here to see the original:
Nanotechnology in Medical Applications Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 - Market Forecast

Posted in Nano medicine | Comments Off on Nanotechnology in Medical Applications Market: Strategic Analysis to Understand the Competitive Outlook of the Industry, 2025 – Market Forecast

Global Nanorobots Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2024 – Pioneer Reporter

Posted: September 22, 2019 at 5:44 pm

WiseGuyRerports.com Presents Global Nanorobots Market 2019 by Company, Regions, Type and Application, Forecast to 2024 New Document to its Studies Database

According to the latest report added to the online inventory of Wise Guys Report (WGR) the global Nanorobots market has witnessed an unprecedented rise and the extrapolated growth indicates further growth to $85 billion by 2024 registering a record CAGR of 21.5% during the forecast timeline.Nanorobots are the FDA approved new generation nanomachines that come with a wide spectrum of new therapies. Basically it is a tiny machine that is programmed to achieve certain tasks once or repeatedly in particular parts with high precision. Nanorobots are mainly used to treat cancer bytransforming them into drug carrying vendors. These drugs which are usually toxic medications are administered directly to the effected region with high precision without compromising the healthy tissues in the surrounding regions. It is the medical characteristics of nanorobots that has propelled the expansion in research and development of nanorobots in the healthcare vertical for the creation of nanomedicines. Currently nanomedicine accounts for the maximum share of the global nanorobotics market.More inclination for safe and reliable healthcare technologies have driven the use of Nanobots in healthcare. Nanobots possess the ability to scan the body for cancer cells. If it locates disputable cells it does further careful analysis post which it destroys the cell using more vigorous mechanisms than what the immune system is designed for. Widespread adoption of nanotechnology among surgeons, specialists and other medical caretakers will only propel and encourage the Nanobots market. The biggest impediment in the global nanorobot market is the cost of any new product that hits the market. This is mainly attributed to the temporary monopoly gained by the manufacturer backed by the patents they have acquired.

Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/4395261-global-nanorobots-market-2019-by-company-regions-type

Global Nanorobots Market: Segmental Analysis

According to the segmental analysis of global nanorobot market the landscape can be bifurcated as per type, application and marketing channel adopted.Based on type the variants of nanorobots available in the market are Microbivore Nanobots, RespirOcyte NamObots, Clottocyte Nanobots and Cellular Repair Nanobots.

Categorized by application nanorobots can be used in Nano Medicine, Biomedical, Mechanical and others. The nanomedicine has more prevalent market presence contributing almost 35% of the Overall share as of 2016. This has been triggered by technological advancements in the field of healthcare giving birth to nano-swimmers, bacteria powered robots and magnetically controlled nanobots that are specifically designed to target cancerous regions in nano-dimensions.

Labelled by marketing channel, the marketing models used in global nanorobot scope are direct marketing, indirect marketing and nanorobots customers.

Global Nanorobots Market: Regional Analysis

Market segmentation by companies engaged in production of nanorobots include enterprises such as Bruker, Lhemo Fisher, Ginkgo BioworkS Oxford Instruments. Ex Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik. Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract Nanonics Imaging, Novascan technologies and Angstrom Advanced.

Complete Report Details @ https://www.wiseguyreports.com/reports/4395261-global-nanorobots-market-2019-by-company-regions-type

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

[emailprotected]

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Continued here:
Global Nanorobots Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2024 - Pioneer Reporter

Posted in Nano medicine | Comments Off on Global Nanorobots Market Prospective Growth, Opportunities, Top Key Players and Forecast to 2024 – Pioneer Reporter

Growing hair on bald heads with electric tech may soon be easy – Livemint

Posted: September 22, 2019 at 5:44 pm

BENGALURU

Reversing baldness could someday be as easy as wearing a hat, thanks to a noninvasive, low-cost hair-growth-stimulating technology, according to engineers at the University of Wisconsin-Madison. Before you jump with excitement, though, do keep in mind that the researchers have only patented the concept with the Wisconsin Alumni Research Foundation, and are yet to test this on humans.

Based on devices that gather energy from a body's daily motion, the hair-growth technology stimulates the skin with gentle, low-frequency electric pulses, which coax dormant follicles to reactivate hair production. The devices don't cause hair follicles to sprout anew in smooth skin. Instead, they reactivate hair-producing structures that have gone dormant.

That means they could be used as an intervention for people in the early stages of pattern baldness, but they wouldn't bestow cascading tresses to someone who has been as bald as a billiard ball for several years. Further, because the devices are powered by the movement of the wearer, they don't require a bulky battery pack or complicated electronics. In fact, they're so low-profile that they could be discreetly worn underneath the crown of an everyday baseball cap.

Xudong Wang, a professor of materials science and engineering at UW-Madison, and his colleagues have published a description of the technology in the journal ACS Nano, the researchers said in 20 September statement.

Wang is a world expert in the design and creation of energy-harvesting devices. He has pioneered electric bandages that stimulate wound-healing and a weight-loss implant that uses gentle electricity to trick the stomach into feeling full.

The hair-growth technology is based on a similar premise: Small devices called nanogenerators passively gather energy from day-to-day movements and then transmit low-frequency pulses of electricity to the skin. That gentle electric stimulation causes dormant follicles to "wake up." "Electric stimulations can help many different body functions," says Wang. "But before our work there was no really good solution for low-profile devices that provide gentle but effective stimulations."

Because the electric pulses are incredibly gentle and don't penetrate any deeper than the very outermost layers of the scalp, the devices don't seem to cause any unpleasant side effects. That's a marked advantage over other baldness treatments, like the medicine Propecia, which carries risks of sexual dysfunction, depression and anxiety.

Read this article:
Growing hair on bald heads with electric tech may soon be easy - Livemint

Posted in Nano medicine | Comments Off on Growing hair on bald heads with electric tech may soon be easy – Livemint

Nano-biotechnology Market by Manufacturer Analysis 2016-2024 – BitGmx

Posted: September 22, 2019 at 5:44 pm

Global Nano-biotechnology Market: Overview

Nanotechnology is referred as the manipulation of matter on the super-molecular, molecular, and atomic scale. The earliest description of nanotechnology is the goal of technologically manipulating the molecules and atoms for the fabrication of macro-scale components, commonly known as molecular nanotechnology. Moving to nano-biotechnology, it refers to the miniaturization of biotechnology and the ways in which nanotechnology can be used for the development of devices employed for studying biological systems, thus aiding in advancing the goals of biology. It is also the branch of nanotechnology that is known for dealing with biochemical and biological uses or applications. Nano-biotechnology also studies the nature of fabricating new nano-devices and elements existing in living organisms. The applications of nano-biotechnology in terms of commercial use in the biomedical field are basically directed towards development new techniques in biosciences and drugs delivery systems.

Although nano-biotechnology is in an infant stage, researchers and scientists are developing several methods that immense scope of development in future, thus increasing the hope of participants that it will yield beneficial results in future. Nano-biotechnology also finds applications in drug delivery systems in target specific therapies, biomarkers, biosensors, molecular imaging, disease diagnosis, and gene therapy. When collaborated with biological research, nano-biotechnology results in the development of high-end innovations in the healthcare industry. Nano-biotechnology has capacities for progressing medical science thus refining health care practices across the globe. Numerous novel nano-particles and nano-devices are anticipated to be employed, with a colossal positive effect on human health. While true clinical applications of nano-technology are still basically inexistent, a noteworthy amount of favorable medical projects are in an advanced experimental stage. Implementation of nanotechnology in physiology and medical means that devices are so precisely designed that they can interrelate with sub-cellular levels of the body with an extraordinary degree of specificity. Thus, therapeutic worth can be attained to extreme with trifling side effects with regards to tissue-specific or targeted cell clinical intervention.

The market research publication is a comprehensive analysis of the growth trajectory in terms of the past, present, and future progress and prospects of the global nano-biotechnology market. It further presents an assessment of the aspects that are expected to influence the growth of the market and the chief trends. The report also offers a diverse understanding of the competitive scenario of the market by utilizing the value chain and Porters five forces analysis. The report highlights the research and development projects, mergers and acquisitions, details on collaborations and licensing. The study also offers information on the marketing strategies, products, and shares of the key players operating in the market.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/nano-biotechnology-market.html

Global Nano-biotechnology Market: Trends and Opportunities

The global nano-biotechnology is likely to witness promising growth owing to the rise in the number of new, promising, and innovative products that are currently undertaking clinical trials. Scientists are confident that these trials will give positive results and nano-biotechnology will help in transforming the prevention process, diagnosis, and treatment of various diseases in the near future. Other than medicine, nano-biotechnology also has potential use in areas such as energy production, electronics, and biomaterials. The increasing applications of nano-biotechnology along with the investments being made public and private companies and organizations is an indication of a bright future for nano-biotechnology. It has been predicted that the products that presently under the pipeline review are likely to find commercial platforms soon.

Like any new introduction in the market, nano-biotechnology is also likely to face several challenges. The primary issues that are expected to have an adverse impact on the market growth are environmental problems and effect of the toxicity of nano-materials on the environment and the global economy. Other threats include uncertainty of product effectiveness, scarce resources, funding, scalability, and the development of proper devices.

Global Nano-biotechnology Market: Regional Outlook

The global nano-biotechnology market has been segmented into Asia Pacific, North America, Europe, and the Rest of the World. The manufacturers of nano-biotechnology devices can gen potential opportunities in the emerging markets in North America and Europe. The United States is investing heavily in the research and development projects of nano-biotechnology and is also implementing flexible policies.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=788&source=atm

Companies Mentioned in the Report

The companies operating in the market are Ablynx, AC Serendip, dermaCM, Dabur Pharma, Xantec Bioanalytics, Cellix, WaveSense, Marina Biotech, BioNano Genomics, and INanoBio among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include North America Asia Pacific Europe Rest of the World

This report gives you access to decisive data such as: Market growth drivers Factors limiting market growth Current market trends Market structure Market projections for the coming years

Key highlights of this report Overview of key market forces propelling and restraining market growth Up-to-date analyses of market trends and technological improvements Pin-point analyses of market competition dynamics to offer you a competitive edge An analysis of strategies of major competitors An array of graphics and SWOT analysis of major industry segments Detailed analyses of industry trends A well-defined technological growth map with an impact-analysis Offers a clear understanding of the competitive landscape and key product segments

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications. The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa) The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain. A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period. Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=788&source=atm

Go here to see the original:
Nano-biotechnology Market by Manufacturer Analysis 2016-2024 - BitGmx

Posted in Nano medicine | Comments Off on Nano-biotechnology Market by Manufacturer Analysis 2016-2024 – BitGmx

Spectrum Pharmaceuticals Inc. (SPPI) and Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) Comparison side by side – CryptoCoinsTribune

Posted: September 22, 2019 at 12:49 am

Since Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) and Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) are part of the Biotechnology industry, they are influenced by compare. The influences particularly affect the institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation of both companies.

Earnings and Valuation

Table 1 demonstrates Spectrum Pharmaceuticals Inc. and Rocket Pharmaceuticals Inc.s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 hightlights the return on equity, return on assets and net margins of the two companies.

Risk & Volatility

Spectrum Pharmaceuticals Inc. has a beta of 2.54 and its 154.00% more volatile than Standard & Poors 500. In other hand, Rocket Pharmaceuticals Inc. has beta of 2.66 which is 166.00% more volatile than Standard & Poors 500.

Analyst Recommendations

The next table highlights the given recommendations and ratings for Spectrum Pharmaceuticals Inc. and Rocket Pharmaceuticals Inc.

Meanwhile, Rocket Pharmaceuticals Inc.s consensus target price is $37, while its potential upside is 167.15%.

Insider & Institutional Ownership

The shares of both Spectrum Pharmaceuticals Inc. and Rocket Pharmaceuticals Inc. are owned by institutional investors at 75.6% and 87.9% respectively. About 1.3% of Spectrum Pharmaceuticals Inc.s share are owned by insiders. Competitively, insiders own roughly 1.6% of Rocket Pharmaceuticals Inc.s shares.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

For the past year Spectrum Pharmaceuticals Inc.s stock price has smaller decline than Rocket Pharmaceuticals Inc.

Summary

On 5 of the 8 factors Spectrum Pharmaceuticals Inc. beats Rocket Pharmaceuticals Inc.

Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkins lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating pediatric diseases. It has two lentiviral vector (LVV) programs under clinical testing to treat fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells; and three LVV programs for the treatment of other rare genetic diseases, as well as an adeno-associated viral vector program, which is under preclinical development. The company has collaboration agreements with Lund University, Sweden; and Centro de Investigaciones Energticas, Medioambientales y Tecnolgicas. The company is headquartered in New York, New York.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Original post:
Spectrum Pharmaceuticals Inc. (SPPI) and Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) Comparison side by side - CryptoCoinsTribune

Posted in Nevada Stem Cells | Comments Off on Spectrum Pharmaceuticals Inc. (SPPI) and Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) Comparison side by side – CryptoCoinsTribune

MS BioSci grad awarded research grant for stem cell therapy for brain injuries – News at Louisiana Tech

Posted: September 22, 2019 at 12:46 am

Sean Berman, who earned his MS in Biological Sciences in 2015 from Louisiana Tech, has recently received a grant from the United States Air Force based on his MS research that focuses on traumatic brain injuries and the potential of stem cell therapy in remediating the associated loss in memory and motor coordination.

Berman is hopeful the research will actually aid in repairing the sort of damage to the brain that combat veterans might have experienced as the results of blasts and that football players might have experienced as the result of blows to the head.

His argument is a logical one.

When veterans are coming home from war, theyre being diagnosed with PTSD and treated as though they have a purely psychological problem, said Berman. Zero attention is being paid to the fact theyve had exposure to blasts, both in training and in combat, resulting in many traumatic brain injuries. The structural integrity of their brain is totally disrupted. To not attempt to repair the structural tissue damage and treat it only as a psychological case is like putting a fresh paint job on a high rise thats on the verge of collapse.

Based on work hes been involved with at Tech, along with some clinical work hes done since, we can see that stem cells can help repair this damaged tissue, he said. The goal of this SBIR (Small Business Innovation Research) grant project is to take military personnel diagnosed with severe PTSD, provide stem cell therapy via an IV infusion, and then follow up with typical PSTD verbal tests that are issued at the VA, but also use an advanced assay (test) to measure discrete amounts of neuro-inflammatory markers that can be found in the peripheral blood.

We are partnering with the company, Quanterix, that has equipment that can measure these proteins at a very precise level, so much so that we can correlate it to the severity of the brain injury and hopefully show improvement in that injury over time, Berman said. If successful, we can extend the impact of this research to the public and other groups prone to concussive injury, such as NSF football players.

Earning the grant an Air Force AFWERX SIBR grant is no small accomplishment. The SIBR program is a highly competitive program that encourages domestic small businesses to engage in both Federal Research and Research and Development that has commercialization potential. AFWERX allows the Air Force to engage across industry, academia, and non-traditional contributors to create transformative opportunities and foster an Air Force culture of innovation. The ultimate aim is to solve problems and enhance the effectiveness of the Air Force.

Berman went to Amherst College undergrad and played football there, so he has some experience with head trauma. When he came to Tech with a year of eligibility left, he was given the opportunity to walk on at Tech as a graduate student.

A couple days after I showed up at Tech for Fall Camp, the NFL settled its concussion lawsuit with the NFLPA (National Football League Players Association) for $765 million, a number thats since been upwardly revised to nearly $1 billion, he said. Definitely a hot topic that was all over the news. Everyones initial reaction was, We need to change the game. Make it safer. End football. Take away tackling.

Berman was perplexed, he said, that no one was saying, We need to find a treatment for concussions.

If you roll your ankle in soccer, there are a handful of different treatment options and protocols, Berman said. If you concuss your brain in football, you simply rest until you get better. It didnt make sense to me that the players, trainers, and a medical team would actively work to treat an ankle sprain, but when it came to your brain, the answer was sleep and rest. So I thought itd be a good idea to study concussions while at Tech and hopefully find a solution and viable treatment option. I think we did that.

Bermans research at Tech was conducted under the guidance of Dr. David K. Mills, professor of Biological Sciences and Biomedical Engineering at Tech. Today, he is back in his hometown of Santa Monica, California working with a team of more than 500 doctors across the United States and internationally who are doing stem cell research.

The majority of the work is being done clinically, looking at restoring all kinds of damaged tissue naturally with stem cells, Berman said. We collect and analyze data on thousands of patients, trying to optimize the therapies to figure out which patients are the best candidates, which routes of stem cell administration are most effective, and what complimentary therapies are required, if any.

Its been a lot of fun, he said, and were seeing some life-changing results.

Read more from the original source:
MS BioSci grad awarded research grant for stem cell therapy for brain injuries - News at Louisiana Tech

Posted in Louisiana Stem Cells | Comments Off on MS BioSci grad awarded research grant for stem cell therapy for brain injuries – News at Louisiana Tech

Stem cells regrow leg’s long bones – WNDU-TV

Posted: September 22, 2019 at 12:45 am

People who suffer catastrophic breaks to their long leg bones usually face multiple surgeries, and all too often, amputation.

Scientists at the University of Arizona have been working for more than 20 years to improve the treatment protocol.

Now, they're using a patient's own fat and 3D printing to regrow long bones.

Yudith Burreal broke her leg when an ATV rolled on her a year ago.

"It was completely missing. They didn't know, it was a big chunk of my bone. It was my tibia bone," she recalled.

Her doctors used her bone and marrow to fix the break. But Burreal ended her plans to go into the military, believing her leg wouldn't support her in training.

University of Arizona researchers are developing a way to fix broken long bones with stem cells, a 3D-printed scaffold and a sensor to monitor exercise that helps bones heal.

"If we can fill our scaffold with these cells, the bone will start to form throughout the length of the scaffold," Dr. John A. Szivek explained.

Stem cells are multiplied in a lab and run with calcium particles through the scaffold between the bone ends. A rod holds it in place for six to nine months. The bone grows in and around the scaffold.

"Lately, we have been successful with removing all of the supporting hardware and showing that supporting the bone that we're regrowing is actually functional tissue, to show that it does not need any additional orthopedic hardware in order to function," Dr. David Margolis said.

This work is funded by a $2 million grant from the United States Department of Defense.

"We believe that using this type of approach could regrow the bones for the soldiers, and they would be able to return to active military service," Szivek said.

Researchers will report the recent success they've had with procedures on sheep to the Food and Drug Administration. If the agency accepts it, a Phase 1 trial of fewer than 10 people could start soon at Banner-University Medical Center in Phoenix.

MEDICAL BREAKTHROUGHSRESEARCH SUMMARYTOPIC: STEM CELLS REGROW LONG BONESREPORT: MB #4630

BACKGROUND: Long bones include the humerus, radius, ulna, femur, tibia and fibula. Fracturing one of these bones can result in an acute, comminuted, or stress fracture. Acute fractures have a dramatic presentation, whereas a stress fracture is not as noticeable and a little more subtle. A comminuted fracture is when the bone is broken down into many little pieces. Normally it takes a massive force to break a long bone, like a car or motorcycle accident. Most car or motorcycle accidents cause a comminuted fracture. Sports injuries like falling while skiing or running into someone during a soccer or football game can also result in the breaking of a long bone. (Source: https://www.texashealth.org/thpg/texas-foot-ankle-orthopedics/conditions-we-treat/lower-extremity-trauma/long-bone-fracture & https://bestpractice.bmj.com/topics/en-us/386)

TREATMENT: Treatments include surgical and non-surgical treatments depending on a patient's health and severity of the fracture. Initial treatment may involve your physician applying a splint to provide comfort and support. Another non-surgical method is a cast and functional brace. Surgical treatment is needed if the patient has an open fracture with wounds that need monitoring or if the fracture never healed after a non-surgical treatment. Surgical procedures include intramedullary nailing, plates and screw, and external fixation. (Source: https://www.texashealth.org/thpg/texas-foot-ankle-orthopedics/conditions-we-treat/lower-extremity-trauma/long-bone-fracture)

REGROWING BONES: John A. Szivek, PhD, Professor, Orthopaedic Surgery, William and Sylvia Rubin Chair of Orthopedic Research, Director, Robert G. Volz Orthopedic Research Laboratory, and Senior Scientist at the Arizona Arthritis Center explains how stem cells are helping regrow bones so that patients do not have to use cadaver bone to replace what was damaged. "The way we're doing that is we start off with creating what's called a scaffold. The scaffold is just a template. That template will help that new bone form in the right shape and structure. And we fill these scaffolds for the patients with their own stem cells. We call them adult stem cells. And we extract those stem cells from the patient's own fat," said Szivek. He adds that there are more benefits to this than former procedures, saying, "The advantage of doing that is there's no rejection potential because we're using the person's own cells. And the other advantage is that if we can fill our scaffold with these cells, the bone will start to form throughout the length of that scaffold." (Source: John Szivek, PhD)

Read the original here:
Stem cells regrow leg's long bones - WNDU-TV

Posted in Texas Stem Cells | Comments Off on Stem cells regrow leg’s long bones – WNDU-TV

A breakthrough in the battle against citrus greening – Gainesville Sun

Posted: September 22, 2019 at 12:45 am

A team researchers, with help from a UF scientist, have figured out how to grow the bacteria, which could lead to treatments and disease-resistant trees.

Washington is known for apples but researchers at Washington State University along with colleagues at the University of Florida may have discovered a long-sought holy grail in the quest to stem citrus greening, the disease that has decimated the Floridas flagship crop.

WSU scientists are able to grow the bacteria that causes citrus greening a major step in the creation of resistant plants or treatments for the disease. Among the researchers is David Gang, professor and director of the Tissue Imaging and Proteomics Laboratory at WSU.

The expertise of everybody involved came together in the perfect combination. Thats how we were able to come up with the idea to do this, Gang said. We figured that there had to be something that everybody was missing something about how the bacterium grows that people just werent considering.

To grow the bacteria, researchers first needed samples of it. And thats where Nabil Killiny, UF associate professor in the Department of Plant Pathology Citrus Research and Education Center, comes in.

As part of his research, Killiny grows the insects that transmit the bacteria to trees and studies the nutrients they require. Killiny provided leaves and stems from infected Hamlin orange trees to the scientists at WSU.

From that, scientists were able to find the right recipe of oxygen, salts, acids, vitamins and other ingredients needed to promote long-term growth of a bacteria something that had stymied earlier efforts.

We always had the bacteria for short term, and then we would lose it. Now we have the bacteria for more than two years and can replicate it very nicely. Its perfect, Killiny said. All of the samples are from Florida. Bacteria have so many strains, and it is possible that the strains in Texas are different from the strains in Florida or the strains in California. Now we have the Florida strain in culture, so Florida will be the first state to get benefits.

Data from Florida Citrus Mutual, a cooperative association of citrus growers, shows how the commercial growth of oranges has shriveled.

In 2003-04, Florida produced about 240 million boxes of the fruit, communications director Andrew Meadows said. Greening was found in 2005, and since then, about 70 million boxes a year have been harvested. About 850,000 acres were planted in oranges; now its about 425,000 acres.

Not all of the decline is due to citrus greening, but Meadows said a big portion of it is. Meadows said the bacteria breakthrough is big.

Its a step forward, most definitely. The research community has been trying to culture the bacteria since we started this fight more than a decade ago, so this is a huge advancement, Meadows said.

The biggest financial impact of the disease is on commercial growers. But citrus greening also kills trees that Florida residents have in their yards and love for the free fruit they provide.

Citrus greening is caused by the candidatus liberibacter asiaticus bacteria and is spread by the Asian citrus psyllid insect, which feeds on the stems and leaves, according to the Florida Department of Citrus.

WSU was awarded a $2 million grant from the U.S. Department of Agriculture two years ago to try to develop the bacteria. Killiny said UF got $500,000 from the grant for its role in the project. A researcher from the University of Arizona also worked on the project.

Citrus greening bacteria create biofilm groups of cells that protect themselves by secreting protective or slimy compounds. The plaque on your teeth is from biofilm bacteria. So is methicillin-resistant staphylococcus aureus, the superbug known as MRSA.

WSU has experts in the field of reproducing bacteria, including Haluk Beyenal, an expert in biofilm culturing. He was able, using the right ingredients in the culturing medium, to grow the bacteria and keep it growing.

The biofilm was pretty much the critical thing. Haluk has figured out how to grow different biofilms, Gang said. Were convinced that anybody who follows the methods we put together will be able to grow this bacteria. Weve been able to make it grow now from different trees that have been infected.

More research needs to be done, but Killiny and Gang said eventually the work will lead to the development of orange trees that are more resistant to greening or to treatments for the disease.

It will be much faster now, in my opinion. You can imagine how many compounds we can test now, Killiny said.

View original post here:
A breakthrough in the battle against citrus greening - Gainesville Sun

Posted in Texas Stem Cells | Comments Off on A breakthrough in the battle against citrus greening – Gainesville Sun

Page 1,348«..1020..1,3471,3481,3491,350..1,3601,370..»